Definitive Contract HHSD200201691946C
Award Date
9/13/16
Potential Completion Date
3/19/18
Potential Value
$548K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $497,911.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Microbiome Health Research Institute Inc. (doing business as Openbiome), a non-profit organization. The contract is for a VRE Decolonization Study, which involves the recruitment and treatment of 23 patients, as well as sample collection, to be performed by a subcontractor, Trustees of Indiana University (Indiana University). The contract does not have a set-aside designation. As a...
This federal contract was awarded by the Centers for Disease Control and Prevention (CDC) to Rhode Island Hospital, a division of Lifespan Corporation, for work related to "MICROBIOME DISRUPTION INDICES". The $520,570 firm-fixed price contract was awarded on September 20, 2016 with a completion date of September 14, 2017. No set-aside designation was used. Rhode Island Hospital, the prime contractor, occasionally partners with its Lifespan affiliate The Miriam Hospital as a...
<p>The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price definitive contract to Open Medicine Institute, Inc., a for-profit organization, for a MCAM PERDIATRIC STUDY. The contract has a potential value of $979,817.00 and a completion date of September 28, 2022. The contract does not have a set-aside designation. No additional information about subcontractors or the broader context of the award was provided.</p>
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $387,955.00 firm fixed price contract to the Board of Regents of the University of Nebraska for in vitro and in vivo human microbiome models research. No set-aside was used for this award. The University of Nebraska is serving as the prime contractor, with Baylor College of Medicine as a subcontractor to perform work related to using complementary in vitro and in vivo models of the human microbiome...
This is a $459,721 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Yale University, a private research university, to conduct research on "Microbiome Disruption Indices." The contract has no set-aside designation. As a subcontractor, the University of Maryland, Baltimore (UMB) is providing frozen patient samples and clinical data to support the research effort. This contract award is part of Yale University's broader portfolio of federal prime...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Beth Israel Deaconess Medical Center, Inc. (Bidmc), a non-profit academic medical center in Boston, Massachusetts. The contract has a ceiling value of $28,512 and is for the procurement of SOMASCAN 11K Array services, which involve specialized medical testing and research capabilities. The contract does not have a set-aside designation, indicating that Bidmc successfully competed...
This is a $283,965 firm fixed-price definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Northwestern University's Sponsored Research division. The contract, which does not have a set-aside designation, was awarded on September 30, 2018 and has a completion date of September 29, 2019. The contracted work involves research to address three key questions regarding the microbiomes of healthcare facility surfaces: 1) what...
This is a $15,589.93 firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to Boston Medical Center Corporation (BMC), a non-profit academic medical center in Boston, Massachusetts. The contract is for CPTAC (Clinical Proteomic Tumor Analysis Consortium) task order services and does not have a set-aside designation. The order is part of a larger NCI Tissue Source Site for Tumor Analysis indefinite...
This is a Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to Virginia Commonwealth University (VCU) for the project "MICROBIOME DISRUPTION INDICES". The contract has a Firm Fixed Price structure and a ceiling value of $322,304.00. The period of performance ends on September 29, 2019. This award does not have a set-aside designation. VCU is a public research university that provides a wide range of services to the federal government, including...
This is a $449,417 firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to The Washington University for a study on "Fecal Microbiome Disruptions." The Washington University, a private research university, is serving as the prime contractor on this award. The contract does not appear to have any set-aside designation. The Washington University has extensive experience partnering with federal agencies like the Department of Defense, Department of...